drugset / Trial / NCT06679036

A Trial of HRS-2189 in Combination With Fluvastatin±HRS-6209, or HRS-8080±HRS-6209, or HRS-6209+HRS-1358 in Breast Cancer Patients

NCT06679036

Phase 1/2 Recruiting 300 enrolled Shandong Suncadia Medicine Co., Ltd.
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The study is being conducted to evaluate the efficacy, and safety of dexmedetomidine hydrochloride nasal spray for preoperative sedation in adults. To explore the reasonable dosage of dexmedetomidine hydrochloride nasal spray for preoperative sedation.

Timeline

Start
2025-01-21
Primary completion
2026-10-30
Completion
2026-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluvustat Unknown
Subject HRS-1358 Unknown
Subject HRS-2189 Unknown
Subject HRS-6209 Small molecule
Subject HRS-8080 Unknown

Indications